China SXT Pharmaceuticals (NASDAQ:SXTC) Shares Down 1.3% - Here's What Happened

Key Points

• Shares of China SXT Pharmaceuticals (NASDAQ:SXTC) fell by 1.3%, trading at $1.54 after hitting a low of $1.50 during the session.
• The stock's trading volume increased by 30% to 84,835 shares compared to its average volume of 65,272 shares.
• China SXT Pharmaceuticals specializes in the research, development, manufacture, and sale of traditional Chinese medicine products in China.

China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC - Get Free Report)'s stock price dropped 1.3% on Tuesday . The company traded as low as $1.50 and last traded at $1.54. Approximately 84,835 shares traded hands during mid-day trading, an increase of 30% from the average daily volume of 65,272 shares. The stock had previously closed at $1.56.

Wall Street Analyst Weigh In

Separately, Wall Street Zen raised China SXT Pharmaceuticals from a "sell" rating to a "hold" rating in a research report on Saturday.

China SXT Pharmaceuticals Trading Up 9.0%

The stock has a 50-day moving average of $1.70 and a 200 day moving average of $2.43.

About China SXT Pharmaceuticals

China SXT Pharmaceuticals, Inc, a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen.